Keros Therapeutics names Anne Prener to its board of directors

Go back to Keros Therapeutics names Anne Prener to its board of directors
(NASDAQ: KROS) Delayed: 11.07 --0 (-0%)
Previous Close $11.07    52 Week High
Open $11.07    52 Week Low
Day High $11.07    P/E N/A 
Day Low $11.07    EPS
Volume 130